Our two state-of-the-art R&D divisions in Hyderabad is staffed by nearly 300 qualified scientists. The labs engage in Formulation Development, Analytical Method Development, API Process Development and Stability Studies. Our expertise includes synthesis of complex drug molecules such as LMWH, Corticosteroids, Peptides and Cytotoxic molecules.
As a vertically integrated company, we have seamlessly combined our expertise in research and development (R&D) with state-of-the-art manufacturing set-ups. Together with stringent quality control systems, extensive experience in regulatory procedures, established marketing and distribution infrastructure.
Our exemplary regulatory compliance track record can be gauged from the fact that all our facilities are USFDA approved. Other key global approvals include MHRA (UK), EMA (EU), TGA (Australia), ANVISA (Brazil) and BGV Hamburg (Germany).
Our 4 API manufacturing facilities have in-house manufacturing capabilities that help us integrate backwards and develop products that many others may overlook because of API supply uncertainty.Know More
Our four best-in-class, cGMP- compliant formulation manufacturing facilities manufacture a wide range of injectables using aseptic filling or terminal sterilization, as applicable.Know More